Table 1.
Relative change† | |||||
---|---|---|---|---|---|
Variable | Before OC | During OC | P* | Mean(±SD) | Median (95% CI, %) |
17β-estradiol [pg/ml] | 31(20-65) | 14(8-19) | 0.012 | −56.7(±23.1) | −63.8 (−76 to −37.4) |
Progesterone [ng/ml] | 0.65(0.3-1) | 0.5(0.2-0.6) | 0.011 | −33.4(±14.2) | −33.3 (−45.3 to −21.5) |
FSH [U/l] | 5.25(0.7-8.1) | 0.5(0.1-3.5) | 0.012 | −82.1(±17.3) | −87.8 (−96.5 to −67.7) |
LH [U/l] | 4.3(0.2-7.9) | 0.35(0.1-4.5) | 0.011 | −73.8(±23.1) | −81.4 (−93 to −54.6) |
SHBG [nmol/l] | 54(19-79) | 151.5(47-190) | 0.012 | 205(±207) | 130 (32.2 to 377) |
P: Wilcoxon signed rank test for paired data, comparing women not taking OC with women taking OC.
: Percentage ratio of the means during OC (study day 22, after the 19th OC dose) relative to before OC (study day 1).